Taken together, CD73 depletion increased the presence of tumor-infiltrating CD8+ T cells, and the combination of CD73 blockade with PD-1 inhibitors resulted in enhanced effects on improving the tumor immune microenvironment compared to single-agent treatments. This evidence concerns the gene CD8A and neoplasm.